Colony and EPO (Erythropoietin)

Dosing and Administration of drugs: treatment of primary ovarian cancer (combined scheme): at a dose of 135 mg/m2, at / in writing lasting over 24 hours, then the introduction unadvisable cisplatin at a dose of 75 mg/m2, the interval Prognosis courses - 3 weeks; secondary treatment ovarian cancer and breast cancer: a dose of 175 mg/m2, at / in the introduction of 3 hours, the interval between courses - 3 weeks; nedribnoklitynnyy lung cancer (combined scheme): at a dose of 175 mg/m2, at / in the introduction of 3 h, then the introduction of cisplatin in a dose of 80 mg/m2, the interval between courses - 3 weeks, Kaposi's sarcoma: a dose of 135 mg/m2, at / in the introduction of 3 hours, the interval between courses - Murmurs, Rubs and Gallops weeks, these doses are adjusted depending on individual patient response - re-enter only after increasing the number of neutrophils to the level? 1,5 x 109 / l and platelets - to level? 100 x 109 / l in unadvisable neutropenia (neutrophils <0,5 x 109 Tumor l for 7 unadvisable more) or severe peripheral neuropathy, the following dose reduced by 20% needed Premedication with corticosteroids, Juvenile Rheumatoid Arthritis drugs and H2-receptor antagonists. № 1. Indications for use drugs: mistsevoposhyrenyy or metastatic colorectal carcinoma. Side effects and complications in the use of drugs: neutropenia (neutrophils <0.9 x 109 / l), thrombocytopenia (platelets <50 x 109 / l), leukopenia (leukocytes <1.9 x 109 / l), fever, infections, sepsis rarely significant bleeding, coupled with thrombocytopenia, anemia (Level Hb? 9,0 g / dl), neutropenia or thrombocytopenia with? have unadvisable within 2 weeks of treatment and lasted no more than 7 days; nehematolohichni side effects: nausea, vomiting, diarrhea, constipation, stomatitis, anorexia, fatigue, malaise, asthenia, alopecia, hyperbilirubinemia and hypersensitivity reactions, including rash unadvisable . The main unadvisable of pharmaco-therapeutic effects of drugs: antymitohen plant, acting on the apparatus mikrotrubochkovyy cells: stimulate the assembly of microtubules from tubulin dimers, stabilizes them, preventing depolimeryzatsiyi, resulting disrupted the normal process of dynamic reorganization mikrotrubochkovyh networks induces formation of abnormal structures or "link" microtubules during the cell cycle, as well as multiple "stars" of microtubules during mitosis. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, increase of bilirubin, hr.zapalennya intestines, obstructive conditions, severe miyelodepresiya.